ArticleNature medicine2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
42 authors.
Steven M HorwitzLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. horwitzs@mskcc.org.ORCID http://orcid.org/0000-0002-6399-2006
Ajit J NirmalDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4139-0618
Jahan Rahman *Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-8755-5890
Ran Xu *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5023-3281
Esther DrillDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-3315-4538
Natasha GalassoLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nivetha GanesanLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Theresa DaveyLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Helen HancockLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leslie PerezLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Catherine MaccaroLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alexandra BahgatLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Evan MarzoukLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elizabeth CathcartLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alison MoskowitzLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ariela NoyLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Anita KumarLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eric JacobsenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
David C FisherDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6915-8584
Neha Mehta-ShahDepartment of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Youn H KimDivision of Oncology, Stanford University, Stanford, CA, USA.
Michael KhodadoustDivision of Oncology, Stanford University, Stanford, CA, USA.
Nikita KotlovBostonGene Corporation, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6393-7357
Anastasia NikitinaBostonGene Corporation, Boston, MA, USA.
Olga KudryashovaBostonGene Corporation, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3320-7764
Valeria ZubarevaBostonGene Corporation, Boston, MA, USA.
Ksenia ZornikovaBostonGene Corporation, Boston, MA, USA.
Nara ShinBostonGene Corporation, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9910-4971
Maria SorokinaBostonGene Corporation, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1541-9480
Sandrine DegryseBostonGene Corporation, Boston, MA, USA.
Ekaterina PostovalovaBostonGene Corporation, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3413-3122
Aleksander BagaevBostonGene Corporation, Boston, MA, USA.
Kinga HosszuDepartment of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-1190-1491
Devin McAvoyDepartment of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jaap J BoelensDepartment of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-2232-6952
Wenchao WuState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Zoe CiantraDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jackson W AppeltDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Christopher TrevisaniDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0009-0005-2112-1148
Sam AmakaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
David M WeinstockDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8724-3907
Santosha A VardhanaLymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.ORCID http://orcid.org/0000-0002-3100-1298
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
39548313What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.